What Makes LC-MS/MS the Definitive Method?

For healthcare organizations and professionals (B2B) · Physician-led · Updated 2026-07-12 · CLIA #45D2048957 · CAP #8722734
Molecular fluorescence imaging — Auspicious Laboratory, Houston
Immunoassay guesses at a class. LC-MS/MS identifies the molecule and quantifies it.CLIA #45D2048957 · CAP #8722734 · Same-day results · Walk-ins welcome
Two independent dimensions of identification. Liquid chromatography separates compounds by their physical and chemical behavior; tandem mass spectrometry then fragments each compound and measures the mass of its fragments — a structural fingerprint. The result is specific identification of the individual analyte, with quantitation, rather than an antibody reacting to whatever in the sample happens to look similar.
🔐 Provider Login📝 Become a Provider📞 (713) 266-0808✉️ info@auspiciouslab.com

Screening vs. definitive

Immunoassay screenLC-MS/MS
IdentifiesA drug class, presumptivelyThe specific molecule and its metabolites
Cross-reactivityA known, frequent problemNot applicable — identification is structural
QuantitationNoYes
DefensibilityPresumptive onlyDefinitive — suitable as a confirmatory result
Blind spotsFentanyl is missed by standard opiate screensFentanyl and norfentanyl targeted directly

A presumptive positive is a hypothesis. Acting on it — clinically or administratively — without definitive confirmation is how people lose medications, jobs and custody over a cross-reaction.

Why quantitation matters clinically

In medication monitoring, the question is often not "present or absent" but "consistent with the prescribed regimen." That requires a number, and a metabolite pattern — see medication monitoring.

FAQ

When is definitive testing warranted?
When the result will drive a clinical or administrative decision, when a screen is unexpected, or when the drug of interest is invisible to the screen — fentanyl being the sharpest example.
What is the turnaround?
See turnaround and logistics. We will give you an SLA, not a vague promise.
Is your lab accredited?
CLIA #45D2048957, CAP #8722734 — the quality system behind it.
Can you customize the panel?
Yes — custom UDT panels, built on medical necessity, not on maximizing billable analytes.
🔐 Provider Login📝 Become a Provider📞 (713) 266-0808✉️ info@auspiciouslab.com

References